NCT05564377 2026-03-18
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
National Cancer Institute (NCI)
Phase 2 Recruiting
National Cancer Institute (NCI)
Institut Bergonié
AstraZeneca
AIO-Studien-gGmbH
Memorial Sloan Kettering Cancer Center
Sanofi